Amisulpride treatment leads to elevated prolactin levels
the verdict
SUPPORTED
the evidence backs this
confidence 82/100
Clinical literature consistently demonstrates that treatment with the atypical antipsychotic amisulpride leads to elevated serum prolactin levels (hyperprolactinemia) due to its dopamine receptor blockade.
Evidence for · 3
Sex differences in schizophrenia: symptomatology, treatment efficacy and adverse effects.
2025 · cited by 13
Paper 0 lists amisulpride among antipsychotics that frequently induce hyperprolactinemia.
See more details
More for · 2
Aripiprazole alleviates the high prolactin levels induced by amisulpride via distinct molecular mechanisms: a network pharmacology and molecular docking study.
2025 · cited by 2
Paper 3 specifically investigates mechanisms of amisulpride-induced prolactin elevation.
Clinical Practice Guideline on the Choice of First Antipsychotic Medicine for Females Experiencing a First-Episode of Psychosis.
2026 · cited by 0
Paper 9 classifies amisulpride among medications carrying a higher risk of prolactin elevation.